优化饮食干预对血液透析继发甲状旁腺功能亢进患者整体健康的影响

doi:10.3969/j.issn.2095-9400.2020.02.016

Abstract
Figure/Table
References (0)
Related Citation (4)

Download: PDF (1368 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To observe the effect of optimized dietary intervention on secondary hyperparathyroidism (SHPT) in patients with maintenance hemodialysis (MHD). Methods: Seventy patients undergoing MHD and SHPT were divided into two groups according to their admission time, with 35 cases in each group. The control group was treated with Alfacalcicol soft capsules, calcium carbonate tablets and other dietary treatments, while an optimized diet intervention was implemented in the intervention group, based on the routine treatment. The experiment lasted for three months. Serum calcium, phosphorus, and whole-parathyroid hormone (iPTH) levels were measured before and after intervention in both groups, and the calcium-phosphorus product was calculated. Meanwhile, every result was given a certain score respectively by using the SF-36 scale. The score refers to the score of all items added in the comprehensive questionnaire. Results: The blood calcium levels were increased after intervention in both groups (P<0.05). The levels of phosphorus, iPTH and calcium and phosphorus were lower (P<0.05), and the decline degree of serum phosphorus, iPTH and calcium and phosphorus product were higher in the intervention group than in the control group (P<0.05). The scores, factors and total scores of the two comprehensive measurement items of SF-36 in intervention group were significantly higher than those in the control group (P<0.01). Conclusion: Optimized dietary intervention can significantly improve serum calcium and phosphorus levels in patients with MHD and SHPT, and effectively improve the scores of SF-36.

Key words： optimizing diet intervention maintenance hemodialysis secondary hyperparathyroidism

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Yan
	WANG Deguang
	WANG Juxia

URL:

https://xb.wmu.edu.cn/EN/10.3969/j.issn.2095-9400.2020.02.016 OR https://xb.wmu.edu.cn/EN/Y2020/V50/I2/162

[1] LO C J, BECK G J, KAYSEN G A, et al. Thyroid function in end stage renal disease and effects of frequent hemodialy-sis[J]. Hemodial Int, 2017, 21(4): 534-541.
[2] 王永业, 李若福. 尿毒症患者心率震荡的变化与甲状旁腺素关系的探讨[J]. 温州医科大学学报, 2016, 46(6): 461-463.
[3] 吴国良. 分析维持性血液透析患者继发性甲状旁腺功能亢进与营养不良的关联性[J]. 中国实用医药, 2018, 13(27): 161-162.
[4] 何咏梅, 杨中顺, 尹帮燕, 等. 醋酸钙片治疗血液透析患者高磷血症的疗效及有效性观察[J]. 国际泌尿系统杂志, 2015, 35(6): 874-876.
[5] 周凌辉, 张恒远, 裴娟, 等. 长疗程西那卡塞治疗维持性血液透析患者难治性继发性甲状旁腺功能亢进症的临床观察[J]. 中国全科医学, 2018, 21(8): 989-992.
[6] RHEE C M, YOU A S, NGUYEN D V, et al. Thyroid status and mortality in a prospective hemodialysis cohort[J]. J Clin Endocrinol Metab, 2017, 102(5): 1568-1577.
[7] 杨晶, 王德光, 张森, 等. 维持性血液透析继发甲状旁腺功能亢进症患者肺功能特征及其影响因素分析[J]. 安徽医科大学学报, 2018, 53(10): 1610-1613.
[8] IGARASHI H, YOSHINO H, HIJIKATA M, et al. Acute suppurative thyroiditis in infected thyroid cyst in an adult patient under hemodialysis[J]. Clin Case Rep, 2017, 5(5): 570-573.
[9] 俞科岚. 36例男性高尿酸血症患者的饮食干预加食疗效果分析[J]. 浙江中医药大学学报, 2010, 34(5): 780-781.
[10] NAGATA S, IKEGAYA N, OGINO S, et al. The resection of thyroid cancer was associated with the resolution of hyporesponsiveness to an erythropoiesis-stimulating agent in a hemodialysis patient with aceruloplasminemia[J]. Intern Med, 2017, 56(7): 805-810.
[11] PAKFETRAT M, DABBAGHMANESH M H, KARIMI Z, et al. Prevalence of hypothyroidism and thyroid nodule in chronic hemodialysis Iranian patients[J]. Hemodial Int, 2017, 21(1): 84-89
[12] 张一帆, 刘琦, 邵国建, 等. 维持性血液透析患者睡眠障碍与脂肪细胞因子水平相关关系[J]. 温州医科大学学报, 2015, 45(11): 831-833.
[13] DA COSTA A B, PELLIZZARI C, CARVALHO G A,
et al. High prevalence of subclinical hypothyroidism and nodular thyroid disease in patients on hemodialysis[J]. Hemodial Int, 2016, 20(1): 31-37.
[14] 陈辉乐, 徐昌隆, 徐晓杰, 等. 终末期肾脏病患者脂联素、炎症和氧化应激变化、透析的影响及其机制[J]. 温州医科大学学报, 2015, 45(3): 190-193.